NEC Bio Therapeutics GmbH
Same addressResearch and experimental development on biotechnology
Basic information of the organization
Indicators extracted from public financial statements
Changes published in the official company registry
Legal representatives of the organization
| Name | Role |
|---|---|
Ralf Thomas Kubli since 11/30/2022 | Managing Director |
Natural persons who ultimately own or control the company, resolved through the shareholder chain
| Name | Ownership |
|---|---|
Vaximm Holding AG | 99.00% |
Company ownership and partner structure
1 shareholder
GmbH structure
Balance sheet accounts extracted from public financial statements
Official financial statements and annual reports
Vaximm GmbHMannheimJahresabschluss zum Geschäftsjahr vom 01.01.2023 bis zum 31.12.2023BILANZAKTIVA
Mannheim, den 12. Dezember 2024 gez. Dörmeier Die Feststellung bzw. Billigung des Jahresabschlusses erfolgte am: 12. Dezember 2024 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Latest news articles and media mentions
Real-time check for insolvency notices from register courts
Check if there are any insolvency proceedings for this company
Real-time document download from the commercial register
Other companies registered at or near this business location
4 nearby organizations
Research and experimental development on biotechnology
Operation of terminal facilities for passenger transport, including bus stations
Management activities of other holding companies
Indicators extracted from public financial statements
Real-time document download from the commercial register
Real-time check for insolvency notices from register courts
Check if there are any insolvency proceedings for this company